Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR);Normativas para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Espańola de Neumología y Cirugía Torácica (SEPAR)

Archivos de Bronconeumologia

Volumn 41, Issue 5, 2005, Pages 272-289

  Alfageme, I ^b   Aspa, J ^b   Bello, S ^b   Blanquer, J ^a   Blanquer, R ^b   Borderias L ^b   Bravo, C ^b   De Celis, R ^b   De Gracia, X ^b   Dorca, J ^b   Gallardo, J ^b   Gallego, M ^b   Menendez R ^b   Molinos, L ^b   Paredes, C ^b   Rajas, O ^b   Rello, J ^b   Rodriguez De Castro F ^b   Roig, J ^b   Sanchez Gascon F ^b   Torres, A ^b   Zalacain R ^b   more..

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; TOBRAMYCIN;

ALCOHOL CONSUMPTION; BRONCHOSCOPY; CHLAMYDOPHILA PSITTACI; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COXIELLA BURNETII; DIAGNOSTIC PROCEDURE; HUMAN; LABORATORY TEST; LEGIONELLA PNEUMOPHILA; MEDICAL SOCIETY; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SMOKING;

EID: 24144495448     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074594     Document Type: Article

References (133)

1. Woodhead MA, Macfarlane, JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987;1:671-4.
2. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Kporpi M, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol. 1993;137:977-88.
3. Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklason B, Bartolomé B. Epidemiology of community acquired pneumonia in adults: a population-based study. Eur Respir J. 2000;15:757-63.
4. Santos de Unamuno C, Llorente MA, Carandell E, Gutiérrez M, Riera J, Ramírez A, et al. Lugar de atención, etiología, y tratamiento de las neumonías adquiridas en la comunidad de Palma de Mallorca. Med Clin (Barc). 1998;110:290-4.
5. Munie M, Hueto J. Epidemiología de las neumonías adquiridas en la comunidad en el Área de Salud I de Navarra. Med Clin (Barc). 1991;97:50-2.
6. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134-41.
7. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J. 2002;20 Suppl 36:20-7.
8. Álvarez FJ, Del Castillo D, García Fernández A, Romero B, Del Rey J, Soto G, Castillo J. Estudio prospectivo de 221 neumonías adquiridas en la comunidad seguidas de forma ambulatoria. Etiología y evolucíon clínico-radiológica. Med Clin (Barc). 2001;116:161-6.
9. Zalacaín R, Talayero N, Achótegui V, Corral J, Barreña I, Sobradillo V. Neumonía adquirida en la comunidad. Fiabilidad de los criterios clínicos para decidir tratamiento ambulatorio. Arch Bronconeumol. 1997;33:74-9.
10. Falguera M, Sacristán O, Nogués A, Ruiz A, García M, Manonelles A, Rubio-Caballero M. Non severe community pneumonia: correlation between cause and severity or comorbidity. Arch Int Med. 2001;161:1866-72.
11. Blanquer J, Blanquer R, Borrás R, Nauffal D, Morales P, Menéndez R, et al. Aetiology of community-acquired pneumoniae in Valencia, Spain: a multicentre prospective study. Thorax. 1991;46:508-11.
12. Molinos L, Fernández R, Gullón JA, Rubinos G, Alonso MA, Escudero C, et al. Neumonía adquirida en la comunidad con tratamiento hospitalario. Interés de la clinica y exámenes complementarios en la predicción de la etiología. Arch Bronconeumol. 1997;33:230-5.
13. Ruiz M, Ewig S, Marcos MA, Martínez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity and severity. Am J Respir Crit Care Med. 1999;160:397-405.
14. Sopena N, Sabriá M, Pedro-Botet ML, Manterola JM, Matas L, Domínguez J, et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis. 1999;18:852-8.
15. Rosón B, Carratalá J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes and outcomes of community acquired pneumonia in patients hospitalised on the basis of conventional admission criteria. Clin Infect Dis. 2001;33:158-65.
16. Menéndez R, Córdoba J, De la Cuadra P, Cremades MJ, Lope-Hontagas JL, Salavert M, Gobernado M. Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community acquired pneumonia. Am J Respir Crit Care Med. 1999;159:1868-73.
17. Ruiz-González A, Falguera M, Nogués A, Rubio Caballero M. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown aetiology? A microbiologic study of lung aspirates in consecutive patients with community acquired pneumonia. Am J Med. 1999;106:385-90.
18. Rosón B, Fernández-Sabé N, Carratalá J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Contribution of a urinary antigen assay (Binax Now) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis. 2004;38:222-6.
19. De Roux A, Marcos MA, García E, Mensa J, Ewig S, Lode H, Torres A, et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest. 2004;125:1343-52.
20. Pachón J, Prado MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis and treatment. Am Rev Respir Dis. 1990;142:369-73.
21. Torres A, Serra-Batllés J, Ferrer A, Jiménez P, Celis R, Cobo E, et al. Severe community acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. 1991;114:312-8.
22. Rello J, Quintana A, Ausina V, Net A, Prats G. A three-year study of severe community acquired pneumonia with emphasis in outcome. Chest. 1993;103:232-5.
23. Leroy O, Santré C, Beuscart C, Georges H, Guery B, Jacquier JM, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med. 1995;21:24-31.
24. Rello J, Rodríguez R, Jubert P, Álvarez B, and the study group on severe community acquired pneumonia. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin Infect Dis. 1996;23:723-8.
25. Rello J, Bodi M, Navarro M, Díaz E, Gallego M, Vallés J. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest. 2003;123:174-80.
26. Zalacaín R, Torres A, Celis R, Blanquer J, Aspa J, Esteban L, et al on behalf of "Pneumonia in the elderly" working group. Area TIR. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur Respir J. 2003;21:294-302.
27. Fernández-Sabé N, Carratalá J, Rosón B, Dorca J, Verdaguer R, Manresa F, Gudiol F. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine. 2003;82:159-69.
28. El Solh AA, Aquiline AT, Dhillon RS, Ramadan F. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med. 2002;166:1038-42.
29. Lim WS, MacFarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J. 2001;18:362-8.
30. Torres A, Dorca J, Zalacain R, Bello S, El-Ebiary M, Molinos L, et al. Community acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med. 1996;154:1456-61.
31. Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk factors and prognosis. Arch Intern Med. 2002;162:1849-58.
32. Marrie TJ. Bacteremic pneumococcal pneumonia: a continuously evolving disease. J Infect. 1992;24:247-55.
33. Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol. 2001;38:77-82.
34. Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med. 1999;160:923-9.
35. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Eng J Med. 2001;344:665-71.
36. Nuorti P, Butler J, Parley M, Harrison L, McGeer A, Kolczak M, et al. The active bacterial core surveillance team. Cigarette smoking and invasive pneumococcal disease. N Engl J Med. 2000;342:681-9.
37. Fernández J, López P, Orozco D, Merino J. Clinical study of an outbreak of Legionnaire's disease in Alcoy, Southeastern Spain. Eur J Clin Microbiol Infect Dis. 2002;21:729-35.
38. Agustí C, Rañó A, Filella X, González J, Moreno A, Xaubet A, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment. Etiology, prognostic factors and associated inflammatory response. Chest. 2003;123:488-98.
39. García-Fulgueiras A, Navarro C, Fenoll D, García J, González-Diego P, Jiménez-Bunuelas T, et al. Legionnaires' disease out-break in Murcia, Spain. Emerg Infect Dis. 2003;9:915-21.
40. Sobradillo V, Ansola P, Baranda F, Corral C. Q fever pneumonia: a review of 164 cases in the Basque Country. Eur Respir J. 1989;2:263-6.
41. Arnal R, Borderías L, Serón C, Zurutuza A. Etiología de la neumonía adquirida en la comunidad que requiere ingreso hospitalario en un període de 39 meses. Arch Bronconeumol. 2002;38 Supl 2:57.
42. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell G, et al. American Thoracic Society Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2001;163:1730-54.
43. Mandell LA, Bartlett JG, Dowell SF, File TM, Jr, Musher DM, Whitney C. Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults. Clin Infect Dis. 2003;37:1405-33.
44. Molinos L, López FJ, Faiña V. Neumonía adquirida en la comunidad. En: Villasante C, editor. Enfermedades respiratorias. Madrid: Aula Médica; 2002. p. 333-40.
45. Dorca J, Bello S, Blanquer JM, De Celis MR, Molinos L, Torres A, et al. Diagnostico y tratamiento de la neumonía adquirida en la comunidad. Arch Bronconeumol. 1997;33:240-6.
46. Luna CM, Ramírez J, López H, Mazzei JA, Abreu de Oliveira JC, Pereira J, et al. Grupo de trabajo de la Asociación Latinoamericana del Tórax (ALAT). Recomendaciones ALAT sobre la neumonía adquirida de la comunidad. Arch Bronconeumol. 2001;37:340-8.
47. Katz DS, Leung AN. Radiology of pneumonia. Clin Chest Med. 1999;20:549-62.
48. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Infectious Diseases Society of America. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31:347-82.
49. MacFarlane J, Bosswell T, Douglas G, Finch R, Holmes W, Honeybourne D, et al. BTS guidelines for the management of community acquired pneumonia in adults. Thorax. 2001;56 Suppl 4:1iv-64iv.
50. MacFarlane JT, Miller AC, Roderick Smith WH, Morris AH, Rose DH. Comparative radiographic features of community-acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis. Thorax. 1984;39:28-33.
51. Franquet T. Imaging of pneumonia: trends and algorithms. Eur Respir J. 2001;18:196-208.
52. Hasley PB, Albaum MN, Fuhrman CR, Britton CA, Marrie TJ, Singer DE, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med. 1996;156:2206-12.
53. Riquelme R, Torres A, El-Ebiary M, De la Bellacasa JP, Estruch R, Mensa J, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Crit Care Med. 1996;154:450-5.
54. Skerrett SJ. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia. Semin Respir Infect. 1997;12:308-21.
55. Arancibia F, Ewig S, Martinez JA, Ruiz M, Bauer T, Marcos MA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med. 2000;162:154-60.
56. Frias J, Gomis M, Prieto J, Mensa J, Bouza E, García- Rodríguez JA, et al. Tratamiento empírico inicial de la neumonía adquirida en la comunidad. Rev Esp Quimioter. 1998;11:255-61.
57. Huchon G, Woodhead M, and the ERS Task Force. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J. 1998;11:986-91.
58. Arancibia F, Ewig S, Martínez J, Ruiz M, Bauer T, Marcos M, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med. 2000;162:154-60.
59. Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the uselfuness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:869-74.
60. García-Vázquez E, Marcos M, Mensa J, De Roux A, Puig J, Font C, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004;164:1807-11.
61. Campbell SG, Marrie TJ, Anstey R, Ackroyd-Stolarz S, Dickinson G. Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department. Emerg Med J. 2003;20:521-3.
62. Craven DE. Blood cultures for community-acquired pneumonia. Piecing together a mosaic for doing less. Am J Respir Crit Care Med. 2004;169:327-35.
63. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med. 2001;95:78-82.
64. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med. 2004;169:342-7.
65. Marcos M, Jiménez de Anta M, De la Bellacasa J, Gonzalez J, Martínez E, García E, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J. 2003;21:209-14.
66. Oosterheert JJ, Bonten MJ, Buskens E, Schneider MM, Hoepelman IM. Algorythm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing. J Clin Microb. 2003;41:4708-13.
67. Roig J, Sabriá M, Pedro-Botet ML. Legionella sp.: community-acquired and nosocomial infection. Curr Opin Infect Dis. 2003;16:145-51.
68. Domínguez J, Blanco S, Prat C, Rivelo R, Sánchez MD, Pallarés MA, et al. Rapid centrifugal method for Legionella antigen concentration in urine samples. Clin Microbiol Infect. 2004;10 Suppl 3:455.
69. Rosón B, Carratalá J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community acquired pneumonia. Arch Intern Med. 2004;164:502-8.
70. Bello S, Chacón E, Hernández A. Técnicas no invasivas en el diagnóstico de las neumonías. Arch Bronconeumol. 1998;34 Supl 2:31-40.
71. Roig J, Soler X, Domingo C, De Celis G. Serological evidence of Legionella species infection in acute exacerbation of COPD. Eur Respir J. 2002;20:504-5.
72. Dominguez J, Gali N, Matas L, Pedroso P, Blanco S, Jiménez M, et al. PCR detection of Streptococcus pneumoniae DNA in serum samples for pneumococcal pneumonia diagnosis. Clin Microbiol Infect. 2001;7:164-6.
73. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of lower respiratory tract illness in the community. Thorax. 2001;56:109-14.
74. García A, Rosón B, Pérez JL, Verdaguer R, Dorca J, Carratalá J, et al. Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol. 1999;37:709-14.
75. Ruiz-Gonzâlez A, Nogués A, Falguera M, Porcel JM, Huelin E, Rubio-Caballero M. Rapid detection of pneumococcal antigen in lung aspirates: comparison with culture and PCR technique. Respir Med. 1997;91:201-6.
76. Jiménez P, Saldias F, Meneses M, Silva ME, Wilson MG, Otth L. Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest. 1993;103:1023-7.
77. Prats E, Dorca J, Pujol M, García L, Barreiro B, Verdaguer R, et al. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J. 2002;19:944-51.
78. Torres A, Fabregas N, Ewig S, Puig de la Bellacasa J, Bauer T, Ramírez J. Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references. Crit Care Med. 2000;28:2799-804.
79. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003;138:109-18.
80. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51:1010-6.
81. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
82. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC, Metlay JP, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med. 1998;158:1350-6.
83. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283:749-55.
84. Arnold FW, Ramirez JA, McDonald LC, Xia EL, España PP, Capelastegui A, et al. Hospitalization for community-acquired pneumonia: the pneumonia severity index versus clinical judgment. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Chest. 2003;124:121-4.
85. Menéndez R, Cremades MJ, Martinez-Moragon E, Soler JJ, Reyes S, Perpiñá M. Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J. 2003;22:643-8.
86. España PP, Capelastegui A, Quintana JM, Soto A, Gorordo I, García-Urbaneja M, et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J. 2003;21:695-701.
87. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med. 2002;166:717-23.
88. Lim WS, Van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.
89. Ewig S, Kleinfeld T, Bauer T, Seifert K, Schafer H, Goke N. Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J. 1999;14:370-5.
90. Ewig S, Ruiz M, Mensa J, Marcos MA, Martínez JA, Arancibia F, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med. 1998;158:1102-8.
91. Kamath A, Pasteur MC, Slade MG, Harrison BD. Recognising severe pneumonia with simple clinical and biochemical measurements. Clin Med. 2003;3:54-6.
92. Ewig S, De Roux A, Bauer T, García E, Mensa J, Niederman M, Torres A. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax. 2004;59:421-7.
93. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 2002;162:1059-64.
94. Pascual FE, Matthay MA, Bacchetti P, Wachter RM. Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest. 2000;117:503-12.
95. Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Sociedad Española de Quimioterapia (SEQ), Sociedad Española de Medicina Interna (SEMI) y Sociedad Española de Medicina de Urgencias y Emergencias (SEMES). Tratamiento antibiótico empírico inicial de la neumonía adquirida en la comunidad en el paciente adulto inmunocompetente. Rev Esp Quimioter. 2003;16:457-66.
96. Aspa J, Rajas O, Rodríguez de Castro F, Blanquer J, Zalacaín R, Fenoll A, et al. Drug-resistant pneumococcal pneumonia: Clinical relevance and related factors. Clin Infect Dis. 2004;38:787-98.
97. Baquero F, García Rodríguez J, García de Lomas J, Aguilar L. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results a multicenter surveillance study. Antimicrob Agents Chemother. 1999;43:357-9.
98. Urban C, Rahman N, Zhao X, Mariano N, Segal-Maurer S, Drlica K, et al. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J Infect Dis. 2001;184:794-8.
99. Ho P, Tse W, Tsang K, Kwok T, Ng T, Cheng V, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis. 2001;32:701-7.
100. Davidson R, Cavalcanti R, Brunton J, Bast D, De Azavedo J, Kibsey P, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med. 2002;346:747-50.
101. Anderson K, Tan J, File T Jr, DiPersio J, Willey B, Low D. Emergence of levofloxacin-resistance pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. Clin Infect Dis. 2003;37:376-81.
102. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004;164:637-44.
103. Battleman DS, Callahan M, Thaler HR. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med. 2002;162:682-8.
104. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 1999;159:2562-72.
105. Brown RB, Ianini P, Gross P, Kunkel M. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Chest. 2003;123:1503-11.
106. Martínez JA, Horcajada P, Almela M, Marco F, Soriano A, Garcia E, et al. Addition of a macrolide to a beta-lactam- based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2003;36:389-95.
107. Fogarty C, Siami G, Kohler R. Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults. Clin Infect Dis. 2004;38 Suppl 1:16-23.
108. Àlvarez-Lerma F, Palomar M, Olaechea P, León C, Sánchez Bermejo B. Estudio observacional sobre el uso de levofloxacino en pacientes ingresados en UCI. Enferm Infecc Microbiol Clin. 2004;22:220-6.
109. Finch R, Schurmann D, Collins O, Kubin R, McGivern J, Bobbaers H, et al. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob Agents Chemother. 2002;46:1746-54.
110. Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras J, Borderías L, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960-5.
111. Radberg G, Nilsson LE, Svensson S. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin. Antimicrob Agents Chemother. 1990;34:2142-7.
112. Siegel RE, Halpern NA, Almenoff PL, Lee A, Cadhin R, Greene JG. A prospective randomized study of inpatient i.v. antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest. 1996;110:965-71.
113. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia. Implications for practice guidelines. JAMA. 1998;279:1452-7.
114. Menéndez R, Torres A, Rodríguez de Castro F, Zalacaín R, Aspa J, Martín Villasclaras J, et al. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 2004;39:1783-90.
115. Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med. 2001;161:722-7.
116. Dunbar LM, Wunderink RG, Habib MP, Smith LG, Tennenberg AM, Khashab MM et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis. 2003;37:752-60.
117. Plouffe J, Schwartz DB, Kolokathis A, Sherman BW, Arnow PM, Gezon PA, et al. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2000;44:1796-802.
118. Mandell LA, File TM. Short-course treatment of community-acquired pneumonia. Clin Infect Dis. 2003;37:761-3.
119. Confalonieri M, Potena A, Carbone G, Porta RD, Tolley EA, Meduri G. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1585-91.
120. Jolliet P, Abajo B, Pasquina P, Chevrolet JC. Non-invasive pressure support ventilation in severe community-acquired pneumonia. Intensive Care Med. 2001;27:812-21.
121. Ferrer M, Esquinas A, Léon M, González G, Alarcón A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med. 2003;168:1438-44.
122. Baudouin SV. The pulmonary physician in critical care. 3: Critical care management of community acquired pneumonia. Thorax. 2002;57:267-71.
123. a ed. Madrid: Elsevier España; 2004. p. 792-9.
124. Menéndez R, Perpiñá M, Torres A. Evaluation of nonresolving and progressive pneumonia. Semin Respir Infect. 2003;18:103-11.
125. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-8):1-24.
126. Fedson DS, Harward MP, Reid RA, Kaiser DL. Hospital-based pneumococcal immunization: epidemiologic rationale from the Shenandoah study. JAMA. 1990;264:1117-22.
127. Fedson DS. Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: a review of its rationale and implications. J Am Geriatr Soc. 1985;33:142-50.
128. Fedson DS, Wajda A, Nicol P, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993;270:1956-61.
129. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-84.
130. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2004;53(RR06):1-40.
131. Margolis KL, Nichol KI, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA. 1990;264:1139-41.
132. Kaplan JE, Katona P, Hurwitz ES, Schonberger LB. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981: lack of an association with influenza vaccination. JAMA. 1982;248:698-700.
133. Harger JH, Ernst JM, Thurnau GR, Moawad A, Momirova V, Landon MB, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002;185:422-7.